High sensitivity of N antigen testing was found in acute phase COVID-19 patients, whereas in convalescent phase and previously infected patients, specific IgM and IgG were presented with high sensitivity, therefore, a combined test of the N antigen and specific antibody may be the optimal method for identifying SARS-CoV-2 infection. This evidence concerns the gene CD40LG and COVID-19.